Restrict 0.5mg Tablet

Product Overview

About Restrict

Restrict is a medication containing the active ingredient Repaglinide, classified as Glinide. Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2.
• Used for: Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Repaglinide, the active ingredient in Restrict, belongs to the Glinide class. 1 INDICATIONS AND USAGE Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Restrict. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Restrict for extended periods without medical advice.